Myocardial infarct (MI) is the world leading cause of morbidity and mortality. The MI severity depends on the extent of the ischemia-reperfusion injury (IRI) that occurs when oxygenated blood returns to tissue after a period of ischemia. A story of success, failure, and hope, the first recognition of IRI as a clinical entity dates back to the 70s [1]. Great hope to treat IRI came in 1986 when ischemic preconditioning (IPC) was discovered [2]. Since then, nearly 35,000 PubMed manuscripts published in the last 10 years met the search for “ischemia reperfusion” (PubMed), 11,300 of which were specifically devoted to IRI in the myocardium.
We are seeking for a highly motivated fellow to join our team collaborating with clinicians on a project aimed at elucidating the molecular bases of left ventricular non-compaction (LVNC) and cardiac dysfunction in muscular dystrophy-associated cardiomyopathies.
A young fellowship position is available in the Group of Cardiovascular Epigenetics headed by Dr. Maria Cristina Vinci in the Unit of Vascular Biology and Regenerative Medicine at Centro Cardiologico Monzino IRCCS.
